ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Singapore health tech mClinica to raise $20m as coronavirus spurs growth

Startup forms supply chains linking makers to wholesalers, retailers in Indonesia, Philippines

mClinica is present in Indonesia, Philippines, Vietnam, Thailand, Malaysia and Cambodia. (Photo by Ken Kobayashi)

JAKARTA -- mClinica, a Singapore-headquartered health tech startup focused on the pharmaceutical industry, is planning to raise $20 million in its Series B round, just months after closing a bridge deal with U.S.-based Susquehanna International Group, a company executive told DealStreetAsia.

The bridge round was closed just before the coronavirus crisis struck the globe, crippling investments across sectors.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more